tafamidis: Clinical Trials

4 trials of tafamidis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 32Completed 2

Follow tafamidis: new trials by email Literature Review of tafamidis trials Research Report on tafamidis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy
Fx-1006A - Cardiomyopathy
Phase 2CompletedPfizer352008-08-012013-01-11
An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy
Fx-1006A - Familial Amyloid Polyneuropathy, ATTR-PN
Phase 2 / Phase 3CompletedPfizer862008-07-012012-12-17
The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis
Fx-1006A - Transthyretin-associated Amyloidosis With Polyneuropathy
Phase 2CompletedPfizer212008-06-012013-01-18
Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis
Fx-1006A, Placebo - Familial Amyloid Polyneuropathy
Phase 2 / Phase 3CompletedPfizer1282007-01-012012-12-17

Conditions studied

Amyloidosis (3)  ·  Polyneuropathies (3)  ·  Alzheimer Disease (2)  ·  Amyloid Neuropathies, Familial (2)  ·  Cardiomyopathies (1)

Sponsors

Pfizer (4)

Countries

France (3)  ·  Germany (3)  ·  United States (3)  ·  Argentina (2)  ·  Brazil (2)  ·  Portugal (2)  ·  Sweden (2)  ·  Italy (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Jeff Packman (2)  ·  Jeff Packman, MBA (1)

Results publications

PMID 31353964, PMID 32107748, PMID 27494299, PMID 29115008, PMID 30558645, PMID 23974642, PMID 24101373, PMID 25872787, PMID 28393570, PMID 28951660